Ever get the feeling your HLD is missing something?
The trophon® device’s unique automated system converts high concentration hydrogen peroxide (H2O2) into mist particles. The droplets of mist are so small they can get into crevices, grooves and tiny imperfections on the probe surface to ensure all the probe has been correctly disinfected.
After disinfection, residual hydrogen peroxide is blown out of the chamber and broken down into environmentally friendly oxygen and water. The trophon device is validated to determine that high-level disinfection is delivered effectively and reproducibly with each cycle.
trophon technology is proven to reach every spot that other methods may miss. That’s why thousands of facilities worldwide trust trophon devices to protect their patients from the risks of ultrasound probe cross-contamination.
Every day our devices provide reliable, automated, traceable HLD for up to 85,000 procedures. That’s over 100 million in the last decade.
Want peace of mind with every HLD cycle?
With trophon technology you’ll ……
The trophon system has been designed with the patient environment in mind, to provide a workflow solution for ultrasound users operating in a range of clinical specialties.
The ability of the trophon device to remove the risk of chemical exposure forms an integral part of its design to maximise staff and patient safety.
Extensive leak testing has been performed as well as risk assessments to demonstrate the operator and patient are at minimal risk of unsafe hydrogen peroxide vapour exposures defined by EH40/2005 introduced by the European Commission Directive (EU) 2017/2398. 1,2
Hydrogen peroxide is a naturally occurring substance in the body.
Commensal lactobacilli in the vagina produce hydrogen peroxide that plays an antibacterial role by preventing growth of bacterial species associated with bacterial vaginosis.3
Hydrogen peroxide is also rapidly degraded into oxygen and water in tissues and mucous.4,5
Hydrogen peroxide is a preferred disinfectant for IVF applications
Hydrogen peroxide has negligible reproductive and developmental toxicity risk according to the European Chemicals Agency (ECHA): “A toxicologically meaningful systemic availability of hydrogen peroxide and transportation of the substance via blood circulation therefore is unlikely. This view is supported by the available repeated dose toxicity studies, which did not result in primary systemic effects. It can be concluded that a data gap with regard to studies of reproductive and developmental toxicity does not exist.” 6
Supporting Documentation
Clinical Bulletin: trophon®: closed, automated disinfection designed for chemical safety. Read here
- Health and Safety Executive. (2020). EH40/2005 Workplace exposure limits (Fourth edition).
- Nanosonics internal leak test reports.
- Hillier SL, et al. Clin Infect Dis. 1993;16 Suppl 4:S273-81.
- Halliwell B, et al. FEBS letters. 2000;486(1):10-3.
- European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC). Special Report No 10: Hydrogen Peroxide OEL Criteria Document. 1996.
- European Chemicals Agency. 2015. Regulation (EU) No 528/2012 concerning the making available on the market and use of biocidal products: Assessment Report Hydrogen Peroxide (March 2015).
- Demeersseman N, Saegeman V, Cossey V, Devriese ir H, Schuermans A, Shedding a light on UV-C technologies in the hospital environment, Journal of Hospital Infection, https://www.journalofhospitalinfection.com/article/S0195-6701(22)00387-5/fulltext.
